AntriaBio Announces $13 Million Close of Private Placement Transaction and Plan to Dose First Patient with AB101 This Month
LOUISVILLE, CO--ANTB, (Marketwired - July 17, 2017) - AntriaBio, Inc. ("AntriaBio or the "Company") (OTCQB: ANTB), a clinical stage biopharmaceutical company specializing in the ...
